Format

Send to

Choose Destination
Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):320-1. doi: 10.1038/nrgastro.2015.78. Epub 2015 May 12.

Therapy. Statins and liver disease: from concern to 'wonder' drugs?

Author information

1
Liver Unit, Hospital Clínic-IDIBAPS, University of Barcelona, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Villarroel 170, Barcelona 08036, Spain.

Abstract

The benefits of statins go beyond decreasing cholesterol levels; in liver disease, statins reduce the risk of progressive liver fibrosis and provide protection during infections and ischaemia–reperfusion injury. New evidence shows that statins improve response to interferon-based anti-HCV therapy, decrease progression to cirrhosis and likelihood of developing hepatocellular carcinoma.

PMID:
25963509
DOI:
10.1038/nrgastro.2015.78
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center